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A B S T R A C T
Colposcopy is a key element in the diagnostic chain required to reduce cervical cancer mortality but it has limitations
in the diagnosis of malignant disease. In the Republic of Croatia the Croatian Society for Colposcopy and Cervical Pa-
thology started constructing guidelines for early detection, therapy and follow-up of patients with early invasive cervical
cancer in order to achieve the best possible results in diagnosis, therapy and follow-up. From 2001 to 2006 Croatian soci-
ety for colposcopy and cervical pathology organised six courses »Role of colposcopy in early diagnosis and prevention of
premalignant lesions of the uterine cervix« in cooperation with Medical faculty, University of Zagreb and the Croatian
medical chamber. Leading presentations were focused on the epidemiology of cervical cancer, cytologic, colposcopic and
pathohistologic classification, HPV testing and role of male partner. After the theoretical part, a series of colposcopic pic-
tures were presented as a practical part of the course where attendees participated in colposcopic images description and
estimation of what could be the underlying pathological process. Such, courses are needed for continued medical educa-
tion and quality practice of colposcopy.
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Introduction
Worldwide, invasive cervical cancer is one of the most
frequent causes of death from gynaecological malign dis-
eases, with almost 500,000 new cases per year1. Half of
cancer cases have a fatal outcome in the first five years
following diagnosis. Its incidence is much higher in de-
veloping countries; it seems that both the incidence and
the mortality rate are rather underestimated in these
countries.
In Croatia, according to the 2003 yearbook, 316 new
cases of invasive cervical cancer (IC) (13.7/100 000) and
493 cases of carcinoma in situ (CIS) were diagnosed. Al-
though the cervical cancer mortality rate is decreasing,
100 women die from this disease every year2.
Colposcopy is a key element in the diagnostic chain
required to reduce cervical cancer mortality but it has
limitations in the diagnosis of malignant disease. Herein,
these limitations and the way of improvement of col-
poscopy are presented.
Limitations of Colposcopy
Colposcopy is necessary if the gynaecologist finds no
unusual features of the cervix in the patient with symp-
toms or an abnormal Pap smear (Figure 1 and 2). Col-
poscopic detection of microinvasive cancer depends on its
size and location (Figure 3). Smaller lesions can be mis-
sed, but the probability of stromal invasion increases
with the size of lesion on the surface of the cervix.
Microinvasive cancers on the ectocervix are character-
ised by atypical blood vessels that are prone to bleeding.
These atypical blood vessels are located unusually, dis-
tributed randomly, vary in diameter, and often change di-
rection forming sharp angles. The intercapillary distance
is also larger than normal and variable.
Invasive carcinomas are visible to the naked eye (Fig-
ure 4), but the colposcope enlarges the image showing
the surface and the atypical blood vessels more clearly.
For example, endophytic tumors often look like erosions
but when enlarged, the papillary surface and atypical
blood vessels are visible allowing a more accurate diagno-
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sis. Keratosis can mask the colposcopic finding of an
endophytic lesion, which is the reason, why biopsy is nec-
essary. Adenocarcinoma has no grossly visible to distin-
guish it from squamous cancers with all of the vascular
changes that have been described so far and a biopsy is
required for its diagnosis. If a firm diagnosis cannot be
made after the biopsy, diagnostic cone biopsy is recom-
mended.
Basic Directives
Colposcopy classifications and achievements evolved
with our understanding of cervical disease and the role of
Human papillomavirus (HPV) infection from the Graz
classification in 1975 to the Rome classification and fi-
nally the Barcelona classification in 20023–5. The Graz
classification3 stated that acetowhite epithelium is a suf-
ficient as an abnormal colposcopic finding. The Rome
classification4 then stated that such epithelium is almost
pathognomonic for HPV infection, and can be more or
less visible, with or without a borderline. Then, the Bar-
celona classification5 added that the acetowhitening can
appear quickly and disappear slowly, or appear slowly
and disappear quickly and this is related to the intensity
of the disruption of intracellular chromatine in the HPV
infected cells.
It is important to recognise that colposcopic classifica-
tion based on the grossly visible features of the cervix is
complemented by both cytological classification6 and pa-
thohistological classification7. This necessitates collabo-
ration between gynaecologists, cytologists and the patho-
logists, to establish protocols for diagnostics and treatment
to achieve the best results. Such a protocol established at
the conference celebrating 75 years of colposcopy in clini-
cal practice, is a protocol for diagnostics and treatment of
premalignant lesions of the cervix and lower genital tract
and this has become a landmark for all of us who deal
with the subject of preinvasive cervical lesions8,9.
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Fig. 1. Slight acetowhitening on the anterior and posterior
lip of the uterine cervix – mild HPV change.
Fig. 2. Coarse acetowhitening – as sign of HPV induced
cervical intraepithelial neoplasia.
Fig. 4. Invasive cancer of the uterine cervix –
pathohistological verification is needed.
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At clinical training courses in colposcopy and early di-
agnostics and prevention of neoplastic changes in the
lower genital tract the theoretical practice ends with the
protocol, and then we present a series of colposcopic im-
ages in order to entice discussion on possible gravity of
lesions and pathohistological verification. Our great in-
terest in the issue led us to the introduction of those ab-
lation and destruction procedures that will spare the cervix
and therefore the reproductive system of our patients,
and their health on the whole.
The cytologic and colposcopic protocol that we estab-
lished for the follow-up after classic probatory excision
by forceps (Kevorkian, Thomas Gaylor) or after pro-
batory excision by loop decreases the number of unneces-
sary cone biopsies by scalpel and diathermic cone biop-
sies by loop.
In cases of persistent cytologic abnormalities, after bi-
opsy, and a second colposcopic examination, it could be
easier to decide on one of such procedures in order to pre-
serve the gynaecological and reproductive health. Al-
though it is necessary to inform the patient that dia-
thermic cone biopsy (LETZ) and classic cone biopsy with
scalpel will remove the site of a potentially serious lesion
the responsibility lies in the hands of the woman (and
her partner) to make sure that such situation does not
repeat in the future.
Common Questions in Colposcopic Practice
What happens when disease progresses? The collabo-
ration of the gynaecologist, the cytologist, and the pa-
thologist implies that the current state of a patient needs
to be discussed on several levels: the stage of the initial
invasion, the sample on which the initial invasion was
discovered, age and parity of the patient. After we con-
sider these levels, we can decide on further treatment of
the patient.
The earlier the cervical cancer is diagnosed, the better
the chances are of successful treatment. However, com-
mon issues that arise in clinical practice are:
• Treatment of microinvasive planocellular cervical can-
cer IA1 diagnosed after LETZ biopsy or classic test ex-
cision by forceps when the patient is a nulliparus, or
has had one or more full term pregnancies?
• Treatment of microinvasive planocellular cervical can-
cer IA2 diagnosed after LETZ biopsy, or after classic
test excision by forceps when the patient is a nul-
liparus, or has had one or more full term pregnancies?
• Treatment of microinvasive planocellular cervical can-
cer IA1 diagnosed after LETZ biopsy or after classic
cone biopsy by scalpel when the patient is a nulliparus
or has had one or more full term pregnancies?
• Treatment of microinvasive planocellular cervical can-
cer IA2 diagnosed after LETZ cone biopsy or after clas-
sic cone biopsy by scalpel. What if the patient is a
nullipara, or if she had a baby once, or more times?
What about the »grey area«? How to treat patients
with stromal invasion of more than 5 mm, the spread
larger than 7 mm, and the change still not visible to the
naked eye? Do they already belong to the IB1 group or
not? What about reproduction? What if the finding is an
incidental finding at hysterectomy, or at a diagnostic
cone biopsy, or at one of the mentioned excohleation of
the cervical canal or probatory excisions? All these issues
require thorough study keeping in mind FIGO classifica-
tion which is one of the more acceptable classification
systems for all those involved in cervical cancer diagnosis
and treatment10,11 (Table 1).
Training Courses in Colposcopy
From 2001 to 2006, the Croatian Society for Col-
poscopy and Cervical Pathology organised six courses on
the theme of the »Role of colposcopy in early diagnosis
and prevention of premalignant lesions of the uterine
cervix«, in cooperation with Medical Faculty of the Uni-
versity of Zagreb and the Croatian Medical Chamber12.
Leading presentations were the epidemiology of cervical
cancer, cytologic, colposcopic and pathohistologic classifi-
cation, HPV testing and role of male partner. After the
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TABLE 1
EXISTING PROTOCOL ON TREATMENT OF PATIENTS WITH ABNORMAL PAP SMEAR AND UNSATISFACTORY COLPOSCOPIC
FINDING OR WITH MICROINVASIVE CARCINOMA OF SQUAMOUS CELLS ON PROBATORY EXCISION
Status of the excision of microinvasion up to 5 mm or less Recommendations
Margins clear with negative ECC, stage IA1 with
no spread to lymphovascular area
 cone biopsy if the patient wants to preserve fertility
Margins and/or ECC positive dysplasia  repeat cone biopsy
 modified radical hysterectomy
 If conisation not appropriate
 Hysterectomy +/– pelvic lymphadenectomy
Stage IA1 with invasion into lymphovascular area  pelvic lymphadenectomy + conisation, or
 radical trachelectomy (for fertility reasons)
 modified radical hysterectomy and pelvic lymphadenectomy
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theoretical lectures there was the practical course based
on series of colposcopic pictures as practical part of
course where attendees participated in colposcopic de-
scription and prediction of the underlying pathological
process. Among 500 gynecologists from Croatia, 60 of
them attended the course and gave the following ratings:
the average grade for quality of presentation was 3.98
points (maximum 5.2) and for quality in everyday prac-
tice was 3.95 points with the highest grading 5.2 points.
Numerous questions and answers due to diagnostic
protocol of early invasive cervical cancer were brought
up during the postgraduate clinical training course »Di-
agnostics, Treatment and Prognosis for Preinvasive Le-
sions and Carcinoma of the Cervix« held at the Obstet-
rics and Gynecology Clinic in Petrova in Zagreb, on 7th
and 8th April 2006. Critical scientific and practical think-
ing and the participation of gynaecologists, pathologists,
cytologists, radiologists and epidemiologists established
firm foundations for a comprehensive insight into this is-
sue.
Conclusion
These foundations created leeway both for experts
and young colleagues in these areas of medicine to work
on setting up a national programme for cervical cancer
screening. Necessary collaboration among complemen-
tary specialities, consulting with more experienced col-
leagues and regular publication of results will improve
women’s gynecologic health care.
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Clinic of Obstetrics and Gynecology, University Hospital »Sisters of Charity«, Vinogradska 29, Zagreb, Croatia
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OGRANI^ENJA KOLPOSKOPIJE U OTKRIVANJU PO^ETNOG INVAZIVNOG
RAKA VRATA MATERNICE
S A @ E T A K
Kolposkopija je klju~ni korak u nizu dijagnosti~kih postupaka potrebnih u spre~avanju smrti od raka vrata maternice,
me|utim metoda ima svoje nedostatke u dijagnostici zlo}udne bolesti. Uvidom u kretanje pojavnosti raka vrata maternice
u Republici Hrvatskoj iskrsava potreba za sveobuhvatnim dijagnosti~ko terapijskom pristupom u {to ranijem otkrivanju,
lije~enju i pra}enju pacijentica s po~etnim invazivnim rakom vrata maternice. To je prioritetni zadatak Hrvatskog dru{tva
za kolposkopiju i bolesti vrata maternice. U okviru postupaka sekundarne prevencije istaknuta je uloga kolposkopije. U
razdoblju do 2001. do 2006. godine Hrvatsko dru{tvo za kolposkopiju i bolesti vrata maternice Hrvatskog lije~ni~kog
zbora organiziralo je u suradnji s Medicinskim fakultetom Sveu~ili{ta u Zagrebu i Klini~kom bolnicom Sestre milosrdnice
{est te~ajeva stalnog medicinskog usavr{avanja prve kategorije »Mjesto i uloga kolposkopije u ranoj dijagnozi i prevenciji
preinvazivnih promjena vrata maternice i donjeg genitalnog trakta. Vode}a poglavlja su bila o pojavnosti raka vrata ma-
ternice, zatim citolo{ka, kolposkopska i patohistolo{ka klasifikacija, testiranje na humani papilomavirus (HPV) te uloga
mu{kog partnera u pojavnosti HPV-a. Nakon teorijskog dijela nastavljen je prakti~ki dio u kojem su polaznici sudjelovali u
opisivanju kolposkopskih slika i o~ekivanju kakva je bila patohistolo{ka pozadina kolposkopskog ispoljavanja. Ovakav
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